Literature DB >> 27541263

Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.

Phoebe F Lamie1, Waleed A M Ali2, Vaclav Bazgier3, Lucie Rárová4.   

Abstract

Two new series of N-substituted indole derivatives 4a-l and 5a-h were synthesized. Their chemical structures were confirmed using spectroscopic tools including IR, (1)H NMR, (13)C NMR mass spectroscopy and elemental analyses. The results showed no significant cytotoxic activity on either cancer or normal human cells. Anti-inflammatory activity for all target compounds was evaluated in vitro. Compounds 5a-h were found to have better anti-inflammatory activity than 4a-l. The inhibitory activity of COX-2 and 5-LOX were tested for 5a-h. Three compounds, 5c, 5d and 5f showed excellent COX-2 inhibitory activity with IC50 ranging from 0.98 to 1.23 μM compared to the reference celecoxib (1.54 μM). These compounds had a reasonable selectivity index between 7.03 and 8.05. Additionally, p-methylbenzoyl derivative 5g (IC50 = 5.78 μM) had superior 5-LOX inhibitory activity, higher than quercetin. 5e was close to quercetin in its LOX inhibitory activity. Compounds 5a-h were docked inside the active site of COX-2 and 5-LOX enzymes.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory activity; Antiproliferative activity; Cyclooxygenase enzymes; Indole derivatives; Molecular docking study

Mesh:

Substances:

Year:  2016        PMID: 27541263     DOI: 10.1016/j.ejmech.2016.08.013

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  10 in total

1.  Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N'-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage.

Authors:  Suhail Razak; Tayyaba Afsar; Nousheen Bibi; Mahmoud Abulmeaty; Wajhul Qamar; Ali Almajwal; Anam Inam; Dara Al Disi; Maria Shabbir; Mashooq Ahmad Bhat
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

2.  Indole Derivatives as Cyclooxygenase Inhibitors: Synthesis, Biological Evaluation and Docking Studies.

Authors:  Mashooq Ahmad Bhat; Mohamed A Al-Omar; Mohammad Raish; Mushtaq Ahmad Ansari; Hatem A Abuelizz; Ahmed H Bakheit; Ahmed M Naglah
Journal:  Molecules       Date:  2018-05-24       Impact factor: 4.411

3.  Novel tetrazole and cyanamide derivatives as inhibitors of cyclooxygenase-2 enzyme: design, synthesis, anti-inflammatory evaluation, ulcerogenic liability and docking study.

Authors:  Phoebe F Lamie; John N Philoppes; Amany A Azouz; Nesreen M Safwat
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

Review 4.  Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect.

Authors:  Zefeng Zhao; Xufen Dai; Chenyang Li; Xiao Wang; Jiale Tian; Ying Feng; Jing Xie; Cong Ma; Zhuang Nie; Peinan Fan; Mingcheng Qian; Xirui He; Shaoping Wu; Yongmin Zhang; Xiaohui Zheng
Journal:  Eur J Med Chem       Date:  2019-11-16       Impact factor: 6.514

5.  An Indole-2-Carboxamide Derivative, LG4, Alleviates Diabetic Kidney Disease Through Inhibiting MAPK-Mediated Inflammatory Responses.

Authors:  Jianchang Qian; Sihui Yin; Lin Ye; Zhe Wang; Sheng Shu; Zhenxin Mou; Mingjiang Xu; Nipon Chattipakorn; Zhiguo Liu; Guang Liang
Journal:  J Inflamm Res       Date:  2021-04-27

6.  Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis.

Authors:  Letizia Crocetti; Claudia Vergelli; Gabriella Guerrini; Maria Paola Giovannoni; Liliya N Kirpotina; Andrei I Khlebnikov; Carla Ghelardini; Lorenzo Di Cesare Mannelli; Elena Lucarini; Igor A Schepetkin; Mark T Quinn
Journal:  Molecules       Date:  2021-10-30       Impact factor: 4.411

Review 7.  Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years.

Authors:  Zhiran Ju; Menglan Li; Junde Xu; Daniel C Howell; Zhiyun Li; Fen-Er Chen
Journal:  Acta Pharm Sin B       Date:  2022-01-11       Impact factor: 14.903

8.  Design and synthesis of new indole drug candidates to treat Alzheimer's disease and targeting neuro-inflammation using a multi-target-directed ligand (MTDL) strategy.

Authors:  Phoebe F Lamie; Maha M Abdel-Fattah; John N Philoppes
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

Review 9.  An insight on medicinal attributes of 1,2,4-triazoles.

Authors:  Ranjana Aggarwal; Garima Sumran
Journal:  Eur J Med Chem       Date:  2020-07-27       Impact factor: 6.514

10.  Computational analysis of eugenol inhibitory activity in lipoxygenase and cyclooxygenase pathways.

Authors:  Francisco das Chagas Pereira de Andrade; Anderson Nogueira Mendes
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.